Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis

Primary Myelofibrosis (PMF) is a chronic Philadelphia-negative myeloproliferative neoplasm characterized by a skewed megakaryopoiesis and an overproduction of proinflammatory and profibrotic mediators that lead to the development of bone marrow (BM) fibrosis. Since we recently uncovered the upregula...

Full description

Bibliographic Details
Main Authors: Elisa Bianchi, Samantha Ruberti, Sebastiano Rontauroli, Paola Guglielmelli, Simona Salati, Chiara Rossi, Roberta Zini, Enrico Tagliafico, Alessandro Maria Vannucchi, Rossella Manfredini
Format: Article
Language:English
Published: MDPI AG 2017-01-01
Series:International Journal of Molecular Sciences
Subjects:
MYB
Online Access:http://www.mdpi.com/1422-0067/18/1/145
id doaj-55b27d113e5045e1a2482c102bb8ae06
record_format Article
spelling doaj-55b27d113e5045e1a2482c102bb8ae062020-11-24T21:06:33ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-01-0118114510.3390/ijms18010145ijms18010145Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary MyelofibrosisElisa Bianchi0Samantha Ruberti1Sebastiano Rontauroli2Paola Guglielmelli3Simona Salati4Chiara Rossi5Roberta Zini6Enrico Tagliafico7Alessandro Maria Vannucchi8Rossella Manfredini9Centre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCRIMM, Center for Research and Innovation for Myeloproliferative Neoplasms, AOU Careggi and Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCenter for Genome Research, University of Modena and Reggio Emilia, 41125 Modena, ItalyCRIMM, Center for Research and Innovation for Myeloproliferative Neoplasms, AOU Careggi and Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyPrimary Myelofibrosis (PMF) is a chronic Philadelphia-negative myeloproliferative neoplasm characterized by a skewed megakaryopoiesis and an overproduction of proinflammatory and profibrotic mediators that lead to the development of bone marrow (BM) fibrosis. Since we recently uncovered the upregulation of miR-34a-5p in PMF CD34+ hematopoietic progenitor cells (HPCs), in order to elucidate its role in PMF pathogenesis here we unravelled the effects of miR-34a-5p overexpression in HPCs. We showed that enforced expression of miR-34a-5p partially constrains proliferation and favours the megakaryocyte and monocyte/macrophage commitment of HPCs. Interestingly, we identified lymphoid enhancer-binding factor 1 (LEF1) and nuclear receptor subfamily 4, group A, member 2 (NR4A2) transcripts as miR-34a-5p-targets downregulated after miR-34a-5p overexpression in HPCs as well as in PMF CD34+ cells. Remarkably, the knockdown of NR4A2 in HPCs mimicked the antiproliferative effects of miR-34a-5p overexpression, while the silencing of LEF1 phenocopied the effects of miR-34a-5p overexpression on HPCs lineage choice, by favouring the megakaryocyte and monocyte/macrophage commitment. Collectively our data unravel the role of miR-34a-5p in HPCs fate decision and suggest that the increased expression of miR-34a-5p in PMF HPCs could be important for the skewing of megakaryopoiesis and the production of monocytes, that are key players in BM fibrosis in PMF patients.http://www.mdpi.com/1422-0067/18/1/145miR-34a-5pnuclear receptor subfamily 4, group A, member 2 (NR4A2)lymphoid enhancer-binding factor 1 (LEF1)MYBhematopoetic progenitor cellshematopoietic differentiationmegakaryopoiesisprimary myelofibrosismyeloproliferative neoplasmsmacrophage
collection DOAJ
language English
format Article
sources DOAJ
author Elisa Bianchi
Samantha Ruberti
Sebastiano Rontauroli
Paola Guglielmelli
Simona Salati
Chiara Rossi
Roberta Zini
Enrico Tagliafico
Alessandro Maria Vannucchi
Rossella Manfredini
spellingShingle Elisa Bianchi
Samantha Ruberti
Sebastiano Rontauroli
Paola Guglielmelli
Simona Salati
Chiara Rossi
Roberta Zini
Enrico Tagliafico
Alessandro Maria Vannucchi
Rossella Manfredini
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis
International Journal of Molecular Sciences
miR-34a-5p
nuclear receptor subfamily 4, group A, member 2 (NR4A2)
lymphoid enhancer-binding factor 1 (LEF1)
MYB
hematopoetic progenitor cells
hematopoietic differentiation
megakaryopoiesis
primary myelofibrosis
myeloproliferative neoplasms
macrophage
author_facet Elisa Bianchi
Samantha Ruberti
Sebastiano Rontauroli
Paola Guglielmelli
Simona Salati
Chiara Rossi
Roberta Zini
Enrico Tagliafico
Alessandro Maria Vannucchi
Rossella Manfredini
author_sort Elisa Bianchi
title Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis
title_short Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis
title_full Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis
title_fullStr Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis
title_full_unstemmed Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis
title_sort role of mir-34a-5p in hematopoietic progenitor cells proliferation and fate decision: novel insights into the pathogenesis of primary myelofibrosis
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2017-01-01
description Primary Myelofibrosis (PMF) is a chronic Philadelphia-negative myeloproliferative neoplasm characterized by a skewed megakaryopoiesis and an overproduction of proinflammatory and profibrotic mediators that lead to the development of bone marrow (BM) fibrosis. Since we recently uncovered the upregulation of miR-34a-5p in PMF CD34+ hematopoietic progenitor cells (HPCs), in order to elucidate its role in PMF pathogenesis here we unravelled the effects of miR-34a-5p overexpression in HPCs. We showed that enforced expression of miR-34a-5p partially constrains proliferation and favours the megakaryocyte and monocyte/macrophage commitment of HPCs. Interestingly, we identified lymphoid enhancer-binding factor 1 (LEF1) and nuclear receptor subfamily 4, group A, member 2 (NR4A2) transcripts as miR-34a-5p-targets downregulated after miR-34a-5p overexpression in HPCs as well as in PMF CD34+ cells. Remarkably, the knockdown of NR4A2 in HPCs mimicked the antiproliferative effects of miR-34a-5p overexpression, while the silencing of LEF1 phenocopied the effects of miR-34a-5p overexpression on HPCs lineage choice, by favouring the megakaryocyte and monocyte/macrophage commitment. Collectively our data unravel the role of miR-34a-5p in HPCs fate decision and suggest that the increased expression of miR-34a-5p in PMF HPCs could be important for the skewing of megakaryopoiesis and the production of monocytes, that are key players in BM fibrosis in PMF patients.
topic miR-34a-5p
nuclear receptor subfamily 4, group A, member 2 (NR4A2)
lymphoid enhancer-binding factor 1 (LEF1)
MYB
hematopoetic progenitor cells
hematopoietic differentiation
megakaryopoiesis
primary myelofibrosis
myeloproliferative neoplasms
macrophage
url http://www.mdpi.com/1422-0067/18/1/145
work_keys_str_mv AT elisabianchi roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT samantharuberti roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT sebastianorontauroli roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT paolaguglielmelli roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT simonasalati roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT chiararossi roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT robertazini roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT enricotagliafico roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT alessandromariavannucchi roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
AT rossellamanfredini roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis
_version_ 1716765565732782080